Otsuka Pharmaceutical Factory, Inc becomes 100% shareholder of Diatranz Otsuka Limited
25 Jan 2018
Living Cell Technologies Limited sells its joint venture shares in Diatranz Otsuka Limited for $3m
News
Southland pig facility closed
25 Nov 2016
DOL's pig facility located in Invercargill has been closed.
Argentine (DIA09) clinical trial data published
03 Oct 2016
Data from the Argentine clinical trial has been published
Update to DIABECELL development strategy
25 Jun 2015
Research, development and manufacturing of DIABECELL in New Zealand will cease resulting in a reduction of staff in Auckland as Diatranz Otsuka Limited (DOL) concentrates activities in the United States.